Shuyi Li, MD, PhD

Assistant Professor

Department of Radiation Oncology Emory University School of Medicine


Dr. Shuyi Li is an Assistant Professor in the Department of Radiation Oncology at Emory University School of Medicine. He is also an Assistant Professor in the Department of Biochemistry. 

Dr. Li is actively engaged in both translational and basic science research. His current research interests include DNA repair, radiation biology, development of radiosensitizers for cancer treatment, and drug delivery. Using a genetic approach, he now leads an NIH-funded project to study the role of a novel repair factor in DNA damage response in both cells and mice. The research may help to develop a novel targeted agent for cancer treatment. He was also a former member of NIH Nanomedicine Center to correct sickle cell disease.  Prior to joining Emory, Dr. Li worked in several international hospitals and universities including: 1. The 2nd University Hospital of China Medical University (China);  2. Uppsala University Hospital (Sweden); 3. School of Medicine, Keio University (Japan), 4. Georgia Regents University (Formerly the Medical College of Georgia) (USA); He was a physician with 12-year clinical practicing experience. He was former Associate Professor, the Vice Department Director of the 2nd University affiliated hospital of China Medial University.  Dr. Li was an expert member of the Ministry of Health of China in collaboration with UNICEF to promote Maternal and Child Health Care. He also worked as an industrial fellow and clinical trial consultant in the field of genetic diagnosis, drug and medical device development.

Dr. Li’s scientific and translational contributions are as follows: 1. Development of a technology to sensitize cancer cells to ionizing radiation by a therapeutic single chain antibody fragment. 2. Development of a novel drug delivery platform (US Patent No. 8,535,72), which has been selected as US R& D 100 award. 3. Identification of a complex of human RNA binding proteins that functions directly in DNA repair; 4. Prenatal diagnosis of genetic diseases including Duchenne muscular dystrophy, Down syndrome and Phenylketonuria; 5. Clone of the full-length human sim2 gene cDNA, one of the candidate genes for the Down syndrome phenotype, and characterized the gene expression pattern in humans.

Dr. Li maintains professional memberships in the American Association for Cancer Research, American Society for Biochemistry and Molecular Biology, and Radiation Research Society. Dr. Li has published many papers in peer-reviewed journals, and his research activities are funded through different State and national funding agencies including NIH, GRA. He has received many awards including 2011 US R&D 100 award, and 2009 International Elite of Suzhou Venture Week award.


He obtained his MD from China Medical University in Shenyang, China and PhD from Keio University in Tokyo, Japan and China Medical University. He received his Postdoc training in cancer genetics and gene regulation from Institute of Molecular Medicine and Genetics, Georgia Regents University (formerly the Medical College of Georgia).